Entolimod on Immunosenescence in Healthy Geriatric Subjects Receiving Influenza Vaccination
Status:
Active, not recruiting
Trial end date:
2022-04-30
Target enrollment:
Participant gender:
Summary
Researchers are evaluating the safety and effectiveness of a single administration of
entolimod when administered at the same time as the influenza vaccine (flu vaccine).